Most Popular Deus Medical Products: Analysis of Athletes’ Choices in 2025–2026

Between 2025 and 2026, the Dinespower online store accumulated a substantial volume of data on demand for bodybuilding and strength-sport products. We analysed actual customer orders, the frequency of repeat purchases and the way demand was distributed across different product categories.

Exact sales figures and confidential commercial data are not disclosed. However, the volume of information collected makes it possible to identify which Deus Medical products customers selected most often, which categories maintained the most consistent demand and how the interests of the audience changed throughout the period under review.

The analysis showed that in 2025–2026, customers were interested not only in traditional testosterone products and compounds associated with muscle gain. A significant share of demand also came from products for weight management, maintaining physical condition and supporting recovery.

Below, we examine the Deus Medical products that ranked among the brand’s most frequently ordered items according to Dinespower’s internal data.

How demand for Deus Medical products was analysed

The research was based on anonymised data from actual orders placed with Dinespower during 2025–2026. Rather than focusing on isolated surges in interest, the analysis considered products that demonstrated sustained demand throughout the period under review.

We evaluated several factors:

the ordering frequency of individual products;
the consistency of demand across different months;
the number of repeat purchases;
the distribution of orders across the main product categories;
changes in customer interest in established and newer products.

This article is not a ranking of medical effectiveness. A product’s popularity reflects its level of demand among Dinespower customers, but it does not mean that the product is equally suitable for everyone or that it can be used without considering contraindications.

The research also does not claim to represent the entire international sports pharmacology market. The conclusions presented here are based exclusively on Dinespower order statistics and reflect the choices made by customers of our store.

Which Deus Medical products were ordered most often in 2025–2026

Throughout the period under review, Deus Medical consistently remained one of the most popular brands in the Dinespower product range.

Demand was distributed across several main areas:

testosterone products and compounds associated with muscle gain;
products considered by athletes working towards a leaner and more defined physique;
products used for appetite and body-weight management;
peptides that have gained attention among athletes interested in recovery;
support products used by some customers during hormonal cycles.

Among individual products, particularly strong demand was recorded for Deustropin 4/12, Testomed E250, Testomed C250, Mastermed E200, Primomed 100, Tirzepatide, Retatrutide, BPC-157, TB-500 and Provimed 25.

Customers’ reasons for choosing these products varied. For some, the familiarity of the active ingredient was the deciding factor. Others focused on a convenient form of administration, a fixed concentration or the ability to order several products from the same manufacturer.

Deustropin 4/12, Testomed E250 and Testomed C250: consistent demand for growth hormone and testosterone products

Based on the number of orders, one of the most consistently popular groups consisted of Deustropin 4/12 and products from the Testomed range. These include Testomed E250, based on testosterone enanthate, and Testomed C250, based on testosterone cypionate.

Testosterone products remain a well-established category in bodybuilding, so the high level of interest was expected. Customers frequently selected products with a straightforward composition, a fixed concentration and a familiar administration format.

Testomed E250 and Testomed C250 contain different testosterone esters, which vary in their pharmacokinetics and duration of action. Athletes may therefore consider them within different approaches to cycle planning. However, the choice of a particular compound, the duration of use and the monitoring of relevant health markers should not be based solely on the product’s popularity.

Deustropin 4/12 also regularly appeared among the most frequently ordered products. In sports communities, interest in growth hormone products is traditionally associated with recovery, changes in body composition and maintaining physical condition. However, individual responses depend on many factors, and the use of somatotropin may be accompanied by unwanted effects.

According to Dinespower data, demand for Deustropin and the Testomed range remained consistent throughout the entire research period. This distinguishes the group from products whose popularity changed more noticeably depending on the season or current market trends.

Mastermed E200 and Primomed 100: interest in physique management and preserving muscle mass

Mastermed E200 and Primomed 100 were also among the most sought-after Deus Medical products in the analysis of orders placed during 2025–2026.

Mastermed E200 contains drostanolone enanthate, while Primomed 100 contains metenolone enanthate. In sports communities, these compounds are more often discussed in the context of improving visual condition, preserving muscle mass and planning cycles that are not focused exclusively on rapidly increasing overall body weight.

Dinespower statistics show that demand for this category was particularly noticeable among customers who were already familiar with sports pharmacology and selected products for a specific training strategy. Unlike basic testosterone products, these items were less likely to appear in a customer’s first purchase but were more frequently included in combined orders.

The popularity of Mastermed E200 and Primomed 100 does not mean that they are free from risks. Both are hormonal products that may affect the lipid profile, endocrine function and other health markers. They are not diuretics and do not guarantee a dry, defined physique without appropriate adjustments to nutrition, training and the overall preparation programme.

Their consistent presence among frequently ordered products instead indicates that part of the Dinespower audience chooses more specialised compounds and builds orders around specific objectives rather than focusing solely on general mass gain.

Tirzepatide and Retatrutide: growing interest in weight and appetite management

One of the most notable changes in the structure of demand during 2025–2026 was growing interest in products associated with appetite regulation and body-weight management.

Within this category, Tirzepatide and Retatrutide stood out in particular. Their popularity reflects a broader trend: customers are increasingly interested not only in traditional fat burners and stimulants but also in newer compounds that affect metabolic signalling and feelings of satiety.

Tirzepatide acts through GIP and GLP-1 receptors. In medical practice, products based on this compound are used for approved indications, but they may cause adverse reactions, particularly involving the gastrointestinal system. It should therefore not be presented as a completely safe or universally suitable weight-loss method.

Retatrutide is a newer compound that acts on GIP, GLP-1 and glucagon receptors. Interest in it is growing rapidly, but its effectiveness and safety remain under investigation. It is therefore especially important to avoid wording that creates the impression that retatrutide is a fully researched product with entirely predictable effects.

According to Dinespower’s internal statistics, demand for both products increased during the period under review. Customer interest was probably influenced by the active discussion surrounding such compounds, changing approaches to weight reduction and a desire to manage appetite without relying on high doses of traditional stimulants.

These products do not remove the need for a balanced diet and should not be used to support extreme food restriction. Reduced appetite also does not guarantee the preservation of muscle mass, adequate energy levels or normal wellbeing.

BPC-157 and TB-500: demand for peptides associated with recovery

Another noticeable trend during 2025–2026 was customer interest in peptide products associated in sports communities with recovery after physical exertion.

Among Deus Medical products, the most frequently ordered items in this category were BPC-157 and TB-500. They were often ordered by athletes experiencing increased strain on their muscles, ligaments and tendons or looking to supplement their recovery programmes.

However, the popularity of these compounds must be considered separately from the strength of the available evidence.

BPC-157 is widely discussed in sports communities, but a substantial proportion of the data on its proposed effects comes from preclinical research. This does not make it possible to guarantee accelerated injury healing or a specific therapeutic outcome in humans.

TB-500 is generally associated with fragments or derivatives of thymosin beta-4. There are also significant limitations regarding its use in sport, and claims of guaranteed tissue recovery or the prevention of chronic injuries would be inaccurate.

The increase in orders for BPC-157 and TB-500 should therefore be interpreted as evidence of audience interest in the recovery-peptide category rather than confirmation of their clinical effectiveness.

For professional athletes, the anti-doping status of any substance used is also important. Some peptides, growth factors and their analogues appear on prohibited-substance lists, so current regulations of the relevant sports federation should always be checked separately before use.

Provimed 25: consistent demand for support products

Provimed 25, based on mesterolone, maintained a stable level of orders throughout the entire research period.

In sports communities, mesterolone is known as an oral androgen. Some athletes consider it a support component within hormonal cycles, partly because the compound itself does not aromatise and can bind to sex hormone-binding globulin.

However, Provimed 25 should not be regarded as a complete substitute for aromatase inhibitors or a universal method of controlling oestrogen. It also does not guarantee the prevention of fluid retention, reduced libido or other possible effects associated with anabolic drug use.

Demand for Provimed 25 was probably influenced by several factors:

recognition of the active ingredient;
its tablet form;
the familiarity of mesterolone within sports communities;
its inclusion in more comprehensive orders.

According to Dinespower statistics, Provimed 25 was more commonly purchased alongside other Deus Medical products than as a standalone item. This supports the trend towards more comprehensively planned orders, in which customers consider not only a primary product but also related items.

However, independently creating such combinations does not eliminate hormonal, cardiovascular or other health risks.

What the 2025–2026 Deus Medical demand analysis revealed

Dinespower’s internal statistics show that customer choices are becoming increasingly diverse. Testosterone products and other traditional anabolic compounds continue to represent a substantial share of demand, while interest in weight management, recovery and support products is growing at the same time.

Several key trends can be identified from the analysis:

Consistent demand for well-established products. Testomed E250, Testomed C250 and Deustropin 4/12 remained popular throughout the entire research period.
Growing interest in modern metabolic products. Tirzepatide and Retatrutide became increasingly prominent in customer orders, reflecting changing approaches to appetite and body-weight management.
Greater attention to recovery. BPC-157 and TB-500 appeared more frequently in orders, although their popularity should not be equated with confirmed clinical effectiveness.
More comprehensive purchasing decisions. Customers often combined established products with specialised and support items, structuring their orders around several objectives at once.

Customers also continued to show an interest in product authenticity and origin, consistent dosing and the ability to purchase several items from a single brand’s product range.

Why product popularity does not guarantee safety

Sales statistics can identify genuine customer preferences, but they cannot replace a medical assessment of a particular compound.

Even a popular and authentic product may have contraindications, interact with other drugs and cause adverse reactions. The risks depend not only on manufacturing quality but also on the active ingredient, dosage, duration of use, individual health status and combination with other products.

Particular caution is required with:

hormonal and anabolic products;
products that affect blood glucose and appetite;
experimental peptide compounds;
combinations of several products;
the use of substances by athletes competing under anti-doping regulations.

Dinespower data should therefore be understood as an analysis of customer demand, not as a recommendation for use or a ready-made cycle protocol.

Conclusions of the Dinespower study

The analysis of actual Dinespower orders placed during 2025–2026 showed that Deus Medical maintained consistent demand across several categories of sports products.

The brand’s most frequently ordered products included Deustropin 4/12, Testomed E250, Testomed C250, Mastermed E200, Primomed 100, Tirzepatide, Retatrutide, BPC-157, TB-500 and Provimed 25.

Traditional testosterone products continue to occupy an important place in the order structure. At the same time, customers are increasingly interested in products for weight management, recovery and more specialised objectives.

The main conclusion of the study is that the market is becoming not only more diverse but also more segmented. Customers are selecting products for specific goals and are increasingly placing combined orders rather than purchasing a single supposedly universal product.

Popularity should not, however, be treated as evidence of safety or a guarantee of a particular result. The Dinespower analysis reflects genuine demand trends and helps explain customer choices, but any decision to use a hormonal, metabolic or peptide-based product requires a separate assessment of the potential risks.